VEGFA and age-related macular degeneration: However not all nAMD patients respond well to anti-VEGF treatment, particularly when CNV develops underneath the detached retinal pigment epithelium, which represents more than 50% of CNV in AMD cases (Type 1 CNV)38,39 and complicates 30–40% of chronic CSCR cases.